Analogs of the Hepatocyte Growth Factor and Macrophage-Stimulating Protein Hinge Regions Act as Met and Ron Dual Inhibitors in Pancreatic Cancer Cells

Anti-Cancer Drugs - United States
doi 10.1097/cad.0000000000000390
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

PET of C-Met in Cancer With 64Cu-Labeled Hepatocyte Growth Factor

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2015English

Role of Macrophage-Stimulating Protein and Its Receptor, RON Tyrosine Kinase, in Ciliary Motility.

Journal of Clinical Investigation
Medicine
1997English

Hepatocyte Growth Factor/C-Met Signaling in Head and Neck Cancer and Implications for Treatment

Cancers
Cancer ResearchOncology
2017English

C-Met Proto-Oncogene (MET; HGFR); Hepatocyte Growth Factor/Scatter Factor (HGF/SF)

Science-Business eXchange
2014English

Synergistic Activities of MET/RON Inhibitor BMS-777607 and mTOR Inhibitor AZD8055 to Polyploid Cells Derived From Pancreatic Cancer and Cancer Stem Cells

Molecular Cancer Therapeutics
Cancer ResearchOncology
2013English

Down-Regulation of MET, the Receptor for Hepatocyte Growth Factor

Oncogene
Cancer ResearchGeneticsMolecular Biology
2001English

Tumorigenicity of the Met Proto-Oncogene and the Gene for Hepatocyte Growth Factor.

Molecular and Cellular Biology
Cell BiologyMolecular Biology
1992English

Expression of Hepatocyte Growth Factor Activator Inhibitors (HAI-1 and HAI-2) in Ovarian Cancer

International Journal of Oncology
Cancer ResearchOncology
1992English

Hepatocyte Growth Factor/C-Met Axis in Thyroid Cancer: From Diagnostic Biomarker to Therapeutic Target

Biomarker Insights
BiochemistryMolecular MedicinePharmacology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy